SANDOZ MIGLUSTAT

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 6db7c32cfdbc3891
Drug Approval Canada Name: SANDOZ MIGLUSTAT
Product Name: SANDOZ MIGLUSTAT
Status: Marketed
Status Date: 2020-04-20
Original Market Date: 2020-04-20
Din: 02456257
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:92.00
Atc Original: A16AX06 MIGLUSTAT
Atc Name: a 16 ax 06
Aig Number: 0150021001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

MIGLUSTAT

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6db7c32cfdbc3891

Type

Standard